Publication details

Substituted propanamides as inhibitors of nucleases

Investor logo
Authors

PARUCH Kamil CARBAIN Benoit Jean-Pierre HAVEL Štěpán VŠIANSKÝ Vít NIKULENKOV Fedor KREJČÍ Lumír

Year of publication 2022
Type Patent
MU Faculty or unit

Faculty of Science

Publisher United States Patent and Trademark Office
State United States of America
Patent's number US11453663
Web https://worldwide.espacenet.com/patent/search?q=pn%3DUS11453663B2
Description Compounds represented by the structural formula (1) where R1, R2, R3, R4, R5, R6 are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info